| GLOBAL
REPORTING ASSESSMENTS
International regulations for clinical trials
safety and post-marketing pharmacovigilance
require expertise and creativity in order
to respond to the initiative of Volume 9A
including electronic reporting (E2B), and
Qualified Persons for Pharmacovigilance
(QPPv) for our complex safety environment.
DSA can assess and prepare your international
regulatory reports and also help you navigate
the complex environment abroad. Ask the
drug safety experts about going global.
Contact
us to learn more about out services.
|